Lantern Pharma (LTRN) EPS (Basic) (2020 - 2026)
Lantern Pharma's (LTRN) quarterly EPS (Basic) came in at -$0.28 in Q2 2026, up 33.45% on a YoY basis from -$0.21 in Q2 2025, and up 6.32% quarter-over-quarter from -$0.3 in Q1 2026.
Powered by 
Analysis
Lantern Pharma (LTRN) EPS (Basic) (2020 - 2026) Analysis & Trends
Lantern Pharma (LTRN) has reported EPS (Basic) for 7 consecutive years, with -$0.28 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EPS (Basic) rose 33.45% year-over-year to -$0.28; the trailing twelve-month figure through Jun 2026 stood at -$1.23 (up 33.55% YoY), and the FY2025 full-year result was -$1.61, up 19.34% from the prior year.
- EPS (Basic) grew to -$0.28 in Q2 2026 per LTRN's latest filing, from -$0.3 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.21 in Q3 2022 and bottomed at -$0.53 in Q4 2024.
- Historically, EPS (Basic) has averaged -$0.4 across 5 years, with a median of -$0.4 in 2022.
- The widest YoY moves for EPS (Basic): up 42.62% in 2022, down 89.33% in 2022.
- Over 5 years, EPS (Basic) stood at -$0.34 in 2022, then fell by 23.76% to -$0.43 in 2023, then dropped by 25.33% to -$0.53 in 2024, then grew by 28.88% to -$0.38 in 2025, then increased by 26.13% to -$0.28 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.28, -$0.3, and -$0.38 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -0.40 |
| 10 | Lantern Pharma | 21.99 Mn | 21.99 Mn | - | -0.28 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.28 |
| Mar 31, 2026 | -0.30 |
| Dec 31, 2025 | -0.38 |
| Sep 30, 2025 | -0.39 |
| Jun 30, 2025 | -0.42 |
| Mar 31, 2025 | -0.43 |
| Dec 31, 2024 | -0.53 |
| Sep 30, 2024 | -0.46 |
| Jun 30, 2024 | -0.49 |
| Mar 31, 2024 | -0.51 |
| Dec 31, 2023 | -0.43 |
| Sep 30, 2023 | -0.30 |
| Jun 30, 2023 | -0.47 |
| Mar 31, 2023 | -0.38 |
| Dec 31, 2022 | -0.34 |
| Sep 30, 2022 | -0.21 |
| Jun 30, 2022 | -0.41 |
| Mar 31, 2022 | -0.39 |
| Dec 31, 2021 | -0.34 |
| Sep 30, 2021 | -0.36 |